Muhammad Sadeqi Nezhad was a Junior Advisor and Research Topic Coordinator and Developer of the research topic entitled “Adoptive T-Cell Therapy, iPSCs Technology, and the CRISPR/Cas9 Genome Editing System: A New Frontier in Cancer Treatment” at Frontiers in Oncology (IF: 5.738). August 2021-September 2022. https://www.frontiersin.org/research-topics/25118/
Topic Editors:
Pro. Dung-Fang Lee (MD Anderson Cancer Center, USA),
Pro. Jianxun J. Song (Texas A&M University Health Science Center, USA),
Pro. Sarwish Rafiq (Emory University School of Medicine, USA), and 3 more Editors.